Ultra-Fast BCMA/CD70 CAR-T Therapy

· Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ultra-Fast BCMA/CD70 CAR-T Therapy, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE [Phase 1]